Othus, Megan
Fred Hutch Cancer Center · SWOG Cancer Research Network
3 papers on CoChatORCID 0000-0001-8176-6371
Most cited papers
- Verified
Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma
Patel, S. P., Othus, M., Chen, Y., Wright, G. P., Yost, K. J., Hyngstrom, J. R., Hu-Lieskovan, S., Lao, C. D., Fecher, L. A., Truong, T.-G., et al. (2023) · New England Journal of Medicine
Cutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers
Cited by 919
- Verified
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Sekeres, M. A., Othus, M., List, A. F., Odenike, O., Stone, R. M., Gore, S. D., Litzow, M. R., Buckstein, R., Fang, M., Roulston, D., et al. (2017) · Journal of Clinical Oncology
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 237
- Verified
Immune checkpoint inhibitors and risk of type 1 diabetes
Chen, X., Affinati, A. H., Lee, Y., Turcu, A. F., Henry, N. L., Schiopu, E., Qin, A., Othus, M., Clauw, D., Ramnath, N., et al. (2022) · Diabetes Care
Cancer Immunotherapy and BiomarkersDiabetes and associated disorders
Cited by 93
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free